Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement
This clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height.
All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 ± 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success.
Read the full article here.
Authors: Ueda, Minoru; Yamada, Yoichi; Ozawa, Ryotaro; Okazaki, Yasuhiro
Source: https://openurl.ebsco.com/
Related articles
Bone regeneration is currently one of the most important and challenging tissue engineering approaches in regenerative medicine.
Endodontics 02 February 2026
Implantology 20 January 2026
Smoking as a risk factor for dental implants and implant-related surgery
Cigarette smoking is known to adversely affect wound healing, and thus may jeopardize the success of dental implantation and implant-related oral surgery.
Products 27 November 2025
Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants
Neocis, the pioneer behind the first and only U.S. FDA-cleared robotic system for dental implant surgery, today announced the launch and FDA approval of its next-generation robotic platform: Yomi...
Read more
Products 21 July 2026
Pre-injection anesthetic spray designed to transform dental injections from a workflow bottleneck into a fast efficient process.
New facility reinforces more than a century of Chicagoland manufacturing excellence while advancing innovation, workforce development, and the future of American-made dental produc
News 21 July 2026
Investment will accelerate InsideDesk’s AI-powered platform, fuel key hires, and extend the company’s leadership in revenue cycle management for dental service organizations.
The forerunner of what’s now Texas A&M College of Dentistry opened 120 years ago in Dallas with the mission of educating dentists to provide quality care to patients in North Texas
Oral pathology 21 July 2026
This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Copyright © 2026 - All Rights Reserved
ISSN 2767-1178